MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma

Archive ouverte

Kinget, Lisa | Roussel, Eduard | Lambrechts, Diether | Boeckx, Bram | Vanginderhuysen, Loïc | Albersen, Maarten | Rodríguez-Antona, Cristina | Graña-Castro, Osvaldo | Inglada-Pérez, Lucía | Verbiest, Annelies | Zucman-Rossi, Jessica | Couchy, Gabrielle | Caruso, Stefano | Laenen, Annouschka | Baldewijns, Marcella | Beuselinck, Benoit

Edité par CCSD ; MDPI -

International audience. Bone metastasis in clear-cell renal cell carcinoma (ccRCC) leads to substantial morbidity through skeletal related adverse events and implicates worse clinical outcomes. MicroRNAs (miRNA) are small non-protein coding RNA molecules with important regulatory functions in cancer development and metastasis. In this retrospective analysis we present dysregulated miRNA in ccRCC, which are associated with bone metastasis. In particular, miR-23a-3p, miR-27a-3p, miR-20a-5p, and miR-335-3p specifically correlated with the earlier appearance of bone metastasis, compared to metastasis in other organs. In contrast, miR-30b-3p and miR-139-3p were correlated with less occurrence of bone metastasis. These miRNAs are potential biomarkers and attractive targets for miRNA inhibitors or mimics, which could lead to novel therapeutic possibilities for bone targeted treatment in metastatic ccRCC.

Suggestions

Du même auteur

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma

Archive ouverte | Kinget, Lisa | CCSD

International audience. Metastatic clear-cell renal cell carcinoma (m-ccRCC) is characterized by increased hypoxia-induced factor (HIF)-2α and vascular endothelial growth factor receptor (VEGFR)-dependent angiogenes...

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

Archive ouverte | Kinget, Lisa | CCSD

International audience. Objective Circulating tumour DNA (ctDNA) is a promising non-invasive biomarker in cancer. We aim to assess the dynamic of ctDNA in patients with hepatocellular carcinoma (HCC). Design We anal...

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab

Archive ouverte | Beulque, Yana | CCSD

International audience. Background and purpose: This study aims to evaluate neutrophil-to-eosinophil ratio (NER) as a prognostic and/or predictive biomarker in metastatic clear cell renal cell carcinoma (m-ccRCC) tr...

Chargement des enrichissements...